Abstract
Various antiepileptic drugs (AEDs) especially enzyme-inducing AEDs might be associated with increased vascular risk, through impairment of the endogenous antioxidative ability which may trigger oxygen-dependent tissue injury. Lamotrigine (LTG) a non-enzyme-inducing AED has scarce information regarding its effects on oxidative stress. The present study aimed to study the possible modulation of vascular risk factors of epileptogenesis by LTG, in a rat model of kindling seizure induced by pentylenetetrazole (PTZ). Four groups of male Wister rats were used; vehicle control group, PTZ group (alternate day PTZ, 30 mg/kg, i.p), LTG/PTZ group (LTG 20 mg/kg/day p.o and alternate day PTZ) and LTG group. The study period was 5 weeks. Lipoproteins and total homocysteine (tHcy), malondialdehyde (MDA) and reduced glutathione (GSH) were measured. Aortic endothelial function study and histopathological examination of the rats' brains, aortas and coronaries were conducted. Serum total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C), tHcy, MDA, GSH levels were significantly higher in epileptic rats than normal controls rats. A decrease in HDL-cholesterol with high atherosclerotic index was also demonstrated. The administration of LTG improved the PTZ-kindled seizures. It produced a significant decrease in TC, TG and LDL-cholesterol, MDA, aortic GSH and increase in HDL-cholesterol with no significant effect on serum GSH and tHcy levels. LTG improved endothelium-dependent relaxation, decreased hippocampal neurodegenerative changes and atherosclerotic changes of aortas and coronaries. LTG decreased seizures severity, hippocampal damage and improved vascular risk markers in this rat model of kindling seizures.
Keywords: Antiepileptic drugs, Epilepsy, Homocysteine, Lamotrigine, Pentylenetetrazole
INTRODUCTION
Epidemiologic studies have shown positive correlations between epilepsy itself and comorbid vascular diseases. Patients with epilepsy suffer mildly increased mortality from ischemic heart disease, with standardized mortality ratios (SMRs) between 1.2 and 2.5 in developed countries. This vascular risk might be further exacerbated by enzymatically active antiepileptic drugs (AEDs) [1]. Process of epileptogenesis and long-term use of certain antiepileptic drugs have been shown to cause increase in plasma concentration of lipoproteins [2], elevated plasma concentration of homocysteine (Hcy) [3], increase in reactive oxygen species [4] and associated vascular endothelial dysfunctions [5].
A number of experimental and clinical reports suggest the involvement of oxidative stress in pathophysiology of epilepsy. The increased free radicals result in membrane lipid peroxidation and decreased glutathione concentrations in the epileptic focus [6]. In addition various antiepileptic drugs especially from the old generation may impair the endogenous antioxidative ability to prevent oxidative stress and trigger oxygen-dependent tissue injury [7].
Homocysteine and its oxidative product, homocysteic acid, are linked with epileptogenesis as they are potent agonists of the N-methyl-D-aspartate (NMDA)-type glutamate receptor [8]. Additionally Hcy reduces the seizure threshold through sequestration of an endogenous anticonvulsant (adenosine) [9]. Up to 20% of patients with homocystinuria and patients with high plasma concentrations of Hcy (50~200 mmol/L) have seizures [10]. At the vascular level during auto oxidation of Hcy in plasma, reactive oxygen species (ROS) are generated. ROS initiate lipid peroxidation in circulating lipoproteins and cell membranes, potentially responsible for endothelial dysfunction [11]. Elevated plasma Hcy has been associated with cardiovascular disease in multiple large-scale epidemiologic studies and, consequently, it is considered as an independent risk factor for atherosclerosis [12].
Chuang and his colleagues [13] compared the long-term impact of different categories of AEDs monotherapy on atherosclerosis development. The team recruited 160 adult patients with epilepsy who had received AEDs monotherapy for more than 2 years, common carotid artery (CCA) intima media thickness (IMT) a measurement used to assess the extent of atherosclerosis. Patients who were under long-term monotherapy with; phenytoin, carbamazepine or valproic acid displayed a significant increase in CCA-IMT measurements. Researchers investigated specific vascular risk factors associated with the type of AED therapy. Epilepsy patients taking carbamazepine or phenytoin for long periods exhibited increased levels of cholesterol, total Hcy and lower levels of folate, all of which increased risk of adverse cardiovascular and cerebrovascular events. Patients who were treated with valproic acid displayed elevated levels of uric acid, Hcy, and thiobarbituric acid reactive substances (TBARS) increasing atherosclerosis risk which the authors believe is based on oxidative mechanisms. The authors argue that drug choice should be carefully selected for epilepsy patients requiring long-term AED treatment, particularly in elderly or individuals at high-risk of vascular events.
The antiepileptic drug lamotrigine (LTG) a non-enzyme-inducing AED acts by blocking voltage-sensitive sodium channels of the neuronal membrane and inhibiting release of excitatory amino acids such as glutamate and aspartate [14]. The information regarding the interactions between LTG and oxidative stress is scarce [13]. The present study aimed to study the possible modulation of vascular and metabolic risk factors of epileptogenesis by LTG, in addition the effect of LTG itself on the process of epileptogenesis was considered in a rat model of epilepsy induced by Pentylenetetrazole (PTZ). PTZ kindling is widely accepted as an experimental animal model for epileptogenesis and estimating the effectiveness of antiepileptic drugs [15].
METHODS
Drugs and chemicals
LTG was a free gift from Indsaff (India). PTZ, phenylephrine and acetylcholine were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Experimental animals
The study was performed in 28 male Wistar rats weighing 150~200 g. The protocol was approved by the Institutional Animal Ethics Committee for Faculty of Medicine, Ain Shams University, Cairo, Egypt. The rats were maintained under standard laboratory conditions with natural light-dark cycle. They were allowed standard pellet diet and tap water ad libitum.
Experimental procedures
PTZ and LTG were freshly prepared throughout the study. PTZ was dissolved in 0.9% saline and injected intraperitoneally (i.p.) on alternate days for 5 weeks. LTG was dissolved in warm water and administered orally (p.o) daily for 5 weeks.
1. Study Design
The rats were randomly divided into 4 groups (7 rats each). Vehicle control group, was given 1ml saline i.p. & p.o. PTZ group, was given PTZ (30 mg/kg, i.p) every other day [16]. PTZ/LTG group, was given LTG (20 mg/kg/day p.o) [17], and alternate day PTZ. LTG group was given LTG (20 mg/kg/day p.o). PTZ was administered until seizure stage 5 on two consecutive trials was achieved. LTG was administered 90 min before PTZ administration.
2. Pentylenetetrazole (PTZ) kindling
The rats were injected with a sub-convulsive dose of PTZ (30 mg/kg) on every alternate day for 5 week then rats were observed for 30 min after each PTZ injection for convulsive behavior. Seizure activity was evaluated using Racine scale [18]: Stage 0: no response; stage 1: hyperactivity, vibrissae twitching; stage 2: head nodding, head clonus and myoclonic jerk; stage 3: unilateral forelimb clonus; stage 4: rearing with bilateral forelimb clonus; stage 5: generalized tonic clonic seizure (GTCS) with loss of writing reflex.
The latencies to GTCS were recorded. The latencies were transformed into seizure score [19] which was calculated using the following formula:
S=1-(control latency/ drug seizure latency) |
Rats were considered kindled if they exhibited stage 5 of seizures on two consecutive trials. The score was zero for PTZ treated rats and one for control rats. Rats were also observed for 24 h mortality.
Blood sampling, tissue preparation and biochemical measurements
Upon completion of epilepsy severity evaluation, blood samples were collected from the femoral vein under urethane anesthesia (1.2 g/kg). Samples were centrifuged for 15 min 5000 rpm. Serum was separated and used for measurement of lipid profile, homocysteine, malondialdehyde and reduced glutathione. Thereafter, the rats were decapitated and the brain, heart and aorta were quickly removed. The heart was cut transversally from the middle. The aorta was divided into 3 parts; one was kept in Krebs solution for isolated organ bath study. The second one was kept in eppendorf and stored at -20℃ till biochemical measurements (samples were homogenized in phosphate buffer (0.5 M; pH=7.0), (1/10 w/v) then centrifuged for 5 min at 700×g at 4℃. Aliquots of homogenates were used for estimation of malondialdehyde and reduced glutathione). The third aortic tissue was kept in formaldehyde 10% with heart and brain for histological studies.
1. Serum lipid profile (mg/dl)
Total serum cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol were estimated by using Synchron cx5 autoanalyzer (Beckman, USA). The atherogenic index was calculated using the formula of Schulpis and Karikas [20] as follows: Atherogenic Index of Plasma (AIP)=Log (TG/HDLC), Triglycerides and HDL-cholesterol in AIP reflect the balance between the atherogenic and protective lipoproteins.
2. Serum total homocysteine (tHcy) measurement
Serum tHcy levels were determined by using rat Hcy ELISA kit (Cusabio, China) according to the manufacture guide.
3. Serum and aortic malondialdehyde (MDA) levels
Lipid peroxidation was determined as thiobarbituric acid reactive substances. It was briefly measured by OxiSelect TBARS Assay Kit (Cell Biolabs, San Diego, USA) according to the manufacture guide.
4. Serum and aortic reduced glutathione (GSH) levels
Reduced glutathione was measured by using Cayman' GSH assay kit (Cayman Chemical, Michigan, USA) according to the manufacture guide.
Vascular reactivity studies:
The excised part of the descending thoracic aorta was removed to a petri dish containing Krebs solution continuously gassed with 95% O2 and 5% CO2 and was carefully cleaned of adherent connective tissue to avoid injury of the endothelial layer. Rings about 7~9 mm width were prepared and mounted between 2 parallel hooks made of stainless steel wire in a 15 ml water jacketed organ bath filled with modified Krebs solution composed of (mM) NaCl (118.2), KCl (4.6), CaCl2.2H2O (1.6), NaHCO3 (24.8), MgSO4 (1.2), KH2PO4 (1.2), MgSO4 (1.2), glucose (10.0), that was continuously gassed with 95% O2 and 5% and temperature was adjusted 37℃ [21]. An initial resting tension of 4 grams was set and the rings were then allowed to equilibrate for 1~2 hrs. Incubation solution was routinely changed every 15 min as a precaution against interfering metabolites. Isometric responses were measured with a force transducer (K30, Hugo Sacks Electronics, Freiburg, Germany) connected to a bridge coupler type 570 and the trace was displayed on a two channel recorder (Lineacorder, HSE, WR3310).
Experimental procedure
After the equilibration period a cumulative concentration response curve to phenylephrine (10-10 M-10-4 M) was constructed by increasing the concentration of phenylephrine, allowing equilibrium to be obtained at each concentration, then the mean effective concentration 50 (EC50) and the maximal contractile response (E-max) to phenylephrine were determined. Endothelium-dependent relaxation was tested by applying acetylcholine (10-9 M-10-4 M) in the same sequence of phenylephrine after adding the concentration of phenylephrine that causes sub-maximal contraction. Percent of acetylcholine induced relaxation in isolated aortic ring was determined.
Brain studies
1. Hippocampal histopathological studies
Five µm thickness paraffin sections of the Hippocampus were stained with H&E and toluidine blue to detect Nissl granules [22].
2. Hippocampal immunohistochemical staining
Caspase-3 technique was used for apoptosis detection and glial fibrillary acidic protein (GFAP) technique was used for detection of astrocytes [23]. Formalin-fixed paraffin sections of the brain were deparaffinized in xylene and rehydrated in ascending grades of ethanol. Endogenous peroxidase activity was quenched with Peroxidase block for 5 minutes. Sections were washed twice in phosphate-buffered saline (PBS). To prevent nonspecific absorption of immunoglobulin, sections were incubated for 10 minutes in Protein block serum-free (Dako Cytomation, Glostrup, Denmark). The slides were divided and then incubated with the appropriate primary antibody (Caspase-3 and GFAP) in a dilution of 1:100 overnight at 4℃. Slides incubated with PBS instead of primary antibody served as negative controls. Sections were then washed twice with PBS. Goat anti-Mouse Peroxidase Conjugated secondary antibody (Dako Cytomation, Glostrup, Denmark) at a dilution of 1:200 was applied to sections and incubated for 30 minutes at room temperature. DAB solution was used and incubated for 10 minutes followed by washing in distilled water and counter staining with haematoxylin. Sections were then cover slipped and examined using light microscopy.
Morphometric studies
Stained sections of hippocampus from each group were examined; five high power fields/ section were chosen to measure: the number of pyramidal cells with positive brownish caspase-3 immuno- reaction and the number of immuno-reactive star-shaped astrocytes stained by GFAP in CA3 region of the hippocampus. The sections were examined using ×40 objective (final magnification ×540) by Zeiss microscope.
Aortic and coronaries histopathological studies
Five µm thickness paraffin sections from heart and thoracic aorta obtained from all groups were stained with Haematoxylin and Eosin stain (H&E).
Statistical analysis
Statistical analysis was carried out using Graphpad prism, software program, version 5.0 (2007). Inc., CA, USA. All values in the results were expressed as means±SD For all parameters, statistical difference among 2 groups was determined by unpaired t-test difference among more than 2 groups was determined using one way analysis of variance; ANOVA followed by Newman-Keuls multiple comparison test. p values<0.05 were considered statistically significant.
In the experiment of phenylephrine induced contraction, all doses were transformed into Log value and the contractile responses for each preparation were expressed as a percentage of the maximum response achieved by each ring separately, which is considered in this cases, the 100% response of that particular ring, the next step was to plot the log concentration against the responses expressed as percentages, in a linear regression curve, then the EC50 as mean±SD for each group were determined.
RESULTS
Effect of lamotrigine on the development of PTZ kindling and seizures scores
Racine score during all treatment period were significantly (p<0.05) lower in PTZ/LTG treated group (Fig. 1A). Repeated administration of a sub-convulsive dose of PTZ (30 mg/kg) on alternate days resulted in increasing convulsive activity leading to generalized tonic clonic seizures (GTCS); stage 5 in two consecutive trials in 27.14±0.83 days in the PTZ group. LTG treatment caused a significant delay in the development of kindling. GTCS stage 5 was observed after 34.0±0.31 days of PTZ injection in the LTG treated group (Fig. 1B). LTG significantly (p<0.05) increased the seizure score from 0 in the PTZ group to 0.2±0.07 (Fig. 1C).
Effect of lamotrigine on lipid profile and atherogenic index
As shown in Table 1 PTZ treated group exhibited a significant increase in serum cholesterol (TC), triglyceride (TG) and low density lipoprotein-cholesterol (LDL-cholesterol), with significant decrease in serum high density lipoprotein-cholesterol (HDL-cholesterol) when compared to control group. PTZ-LTG treated group exhibited a significant decrease in serum TC, TG and LDL-cholesterol with significant increase in serum HDL-cholesterol when compared to PTZ treated group.
Table 1.
Data are expressed as mean±SD, number of animals (n)=7, PTZ (pentylenetetrazole, 30 mg/kg), LTG (lamotrigine, 20 mg/kg). TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol. *p<0.05 compared to control group, †p<0.05 compared to PTZ group by analysis of variance (ANOVA), followed by Newman-Keuls multiple comparison test.
LTG alone group showed significant decrease in all serum lipids, It decreased TC, TG, LDL-cholesterol and HDL-cholesterol when compared to control group. PTZ treated group showed a significant increase in atherogenic risk (increased risk>0.21) while LTG either alone or with PTZ showed a significant decrease in atherogenic risk (low risk<0.11).
Effect of lamotrigine on serum total homocysteine level
Epileptogenesis induced by PTZ induced a significant (p<0.05) increase in serum total homocysteine (tHcy) levels when compared to control group (302.5% increase). LTG treatment either alone or with PTZ did not significantly change tHcy levels (p>0.05) when compared to control group (Fig. 2).
Effect of lamotrigine on serum and aortic malondialdehyde (MDA) level
A significant (p<0.05) increase in MDA levels in serum and aortic tissue were observed in PTZ treated group when compared to control by mean percent change 373.1% and 297.4% respectively. The PTZ-LTG group showed a significant (p<0.05) decrease in MDA levels (serum and aortic) when compared to PTZ treated group by mean percent change (55% and 20.72%). LTG treatment alone caused no significant change in MDA level as compared to the control group in the serum but significant (p<0.05) increase in MDA levels in aortic samples was detected when compared to control group (Fig. 3).
Effect of lamotrigine on serum and aortic reduced glutathione level
A significant (p<0.05) decrease was observed in GSH levels in the PTZ and PTZ-LTG treated groups compared to control group in both serum and aortic tissues with no significant (p>0.05) difference between them. The LTG alone treated group had no significant (p>0.05) change in GSH serum level but a significant (p<0.05) decrease in mean percent change by 23.9% in aortic GSH level was detected compared to control group (Fig. 4).
Correlation between tHcy and both lipid profile and oxidative stress parameters
We performed a correlation analysis between tHcy serum levels and both serum lipids and oxidative parameters to investigate whether tHcy levels were associated with the parameters related to PTZ-induced vascular changes and oxidative stress (Fig. 5). We demonstrated a significant correlation between tHcy and both LDL-cholesterol and TG levels, with insignificant correlation between tHcy and both total cholesterol land HDL-cholesterol levels.
As regard oxidative parameters there was a significant correlation between tHcy and both serum and aortic MDA and GSH levels. These results indicate that tHcy may increase risk of vascular diseases and increase oxidative stress in PTZ-induced epilepsy in rats.
Effect of lamotrigine on endothelial dysfunction studies
Contractile responses to PE significantly (p<0.05) increased in aortas isolated from PTZ treated group when compared to control group with increase in maximum contraction (E-max) induced by 80% and decrease in effective concentration 50 (EC50) by 90%. LTG treatment induced a significant (p<0.05) decrease of E-max and a significant increase in the EC50 (400%) in the aortas isolated from PTZ/LTG treated group when compared to PTZ treated group (Fig. 6A, B).
Endothelium-dependent relaxant response to Ach was significantly (p<0.05) impaired (17.5%) in the aortas isolated from PTZ treated group compared to control group (Fig. 6C). On the other hand LTG treatment in PTZ treated rats significantly (p<0.05) improved the impaired relaxant response caused by PTZ (16.4%).
Effect of lamotrigine on histopathological changes
1. Brain histopathological and immunohistochemical staining changes
PTZ treated group had an apparent decrease in the number of pyramidal cells and their content of Nissl granules in CA3 area of the hippocampus (Fig. 7A2, B2) compared to control group (Table 2, Fig. 7A1, B1). Significant (p<0.05) increase in number of positive brownish caspase-3 immuno- reaction in pyramidal cells and immune GFAP reactive astrocytes were detected (Fig. 7C2, D2) compared to that of control group (Fig. 7C1, D1).
Table 2.
Data are expressed as mean±SD, number of animals (n)=7, PTZ (pentylenetetrazole, 30 mg/kg); LTG (lamotrigine, 20 mg/kg); GFAP, glial fibrillary acidic protein. *p<0.05 compared to control group, †p<0.05 compared to PTZ group by analysis of variance (ANOVA), followed by Newman-Keuls multiple comparison test.
PTZ-LTG treated rats showed an apparent increase number of pyramidal cells and their content of Nissl granules in CA3 area of the hippocampus (Fig. 7A3, B3) compared to PTZ treated group. Moreover, there was a significant (p<0.05) decrease in number of positive brownish caspase-3 immuno- reaction in pyramidal cells and immune GFAP reactive astrocytes (Fig. 7C3, D3) compared to PTZ treated group. LTG alone treated rats showed a picture (Fig. 7A4, B4, C4, and D4) more or less similar to control rats.
2. Aortas and coronaries histopathological changes
Clumps of cells with darkly stained nuclei attached to the endothelium of tunica intima which were apparently irregular were observed in aortas of PTZ treated rats compared to control group (Fig. 8A1). Few of the smooth muscle cells of tunica media showed foamy acidophilic cytoplasm with karyolitic nucleus or clearly vacuolated cytoplasm with peripheral flat pyknotic nucleus (Fig. 8A2). PTZ-LTG treated rats aortas had apparently regular tunica intima lined with darkly stained nuclei. Most of the smooth muscle cells showed acidophilic cytoplasm with rod shaped nuclei, others showed foamy acidophilic cytoplasm and few numbers showed vacuolated cytoplasm with deeply stained nucleus (Fig. 8A3). LTG treated rats aortas showed a picture more or less similar to control rats (Fig. 8A4).
A section of the heart from PTZ treated rats showed multiple vacuoles in the tunica intima and tunica media of the coronary artery with adherence of blood elements to the endothelium, exudates were also seen (Fig. 8B2). PTZ/LTG treated rats showed a coronary artery with few vacuolated cells in tunica media (Fig. 8B3). Meanwhile, LTG treated rats showed a coronary artery with nearly intact tunicae (Fig. 8B4).
DISCUSSION
Epilepsy is one of the major neurological disorders still awaiting safer drugs with improved antiepileptic effect and lesser side effects. Therefore, there is a need to develop AEDs with multiple actions and no/minimal side effect on cardiovascular function [1]. In the present study, sub-convulsive dose of PTZ (30 mg/kg) when given intraperitoneally on alternate days for 5 weeks induced kindling seizure in rats. LTG showed significant protection against seizures. LTG significantly increased the latencies to generalized tonic clonic seizures (GTCS) and decreased the seizure score and lowered the average Racine score compared to PTZ treated rats. As reported previously, LTG prevented seizures in the iron-induced experimental model of epileptogenesis [24] and electroshock induced seizures [25].
Histopathological studies of the hippocampus revealed that epileptogenesis induced by PTZ caused an apparent decrease in the number of the normal pyramidal cells with decrease in its Nissel granules content compared to control group. Along with the presence apoptotic cells as demonstrated by significant increase in number of immune reactive astrocytes with caspase 3 and GFAP when compared to control group, these were in consistence with Gaurav et al. [26]. Their results showed that epileptogenesis is accompanied with decreased CA3c pyramidal cell numbers. LTG administration in the present study showed a decrease in hippocampal damage through an apparent increase in the Nissl granules content of the pyramidal cells and a significant decrease in immune reactive astrocytes with caspase 3 and GFAP in PTZ-LTG treated group when compared to PTZ treated group.
Dyslipidemia has long been known to be an important risk factor for atherosclerosis [27]. The present study showed that epileptogenesis induced by PTZ caused a significant increase in total cholesterol, triglycerides and atherogenic cholesterol (LDL), decrease in HDL and subsequent increase in atherogenic index. LTG administration to epileptic rats in the present study showed a significant decrease in total cholesterol, triglycerides, atherogenic cholesterol (LDL) and atherogenic index with increase in HDL (protective lipoprotein) compared to PTZ group.
Mintzer and colleagues [28] evaluated the effect of switching from the enzyme-inducers, carbamazepine and phenytoin, to the non-enzyme-inducers, LTG. They observed that total cholesterol, atherogenic non-high-density cholesterol and triglycerides, were all lowered suggests that reversal of enzyme induction is the mechanism underlying this improvement. Chuang et al. [13] on the other hand reported that no significant alterations in lipid profile were observed in patients who received long-term LTG monotherapy in comparison to carbamazepine, and phenytoin.
The present study demonstrated that PTZ administration caused a significant increase in serum tHcy in comparison to control rats. Unlüçerçi and colleagues [29] previously reported increase of serum total Hcy levels in epilepsy. In addition, the present study reported a significant correlation between tHyc; LDL-cholesterol, TG, both serum and aortic MDA and GSH. These results indicate that tHcy may increase risk of vascular diseases and increase oxidative stress in PTZ-induced epilepsy in rats. In the present study, LTG did not elevate serum tHcy levels in the epileptic group and this may be an advantageous effect in comparison to the other antiepileptic drugs as previously reported [13,28]. The underlying mechanism for homocysteine increase seems to be a decrease of cofactor molecules in patients using carbamazepine and phenytoin (pyridoxal 5'-phosphate and folic acid, respectively) [30]. Gidal and colleagues [31] demonstrated that 32-week administration LTG had no significant effect on plasma tHcy, plasma red-cell folate and Vitamin B12.
Experimental seizures are known to be associated with a massive release of reactive oxygen species [32]. Indeed an increase in lipid peroxidation has been reported in the hippocampus and cerebral cortex of rodents following PTZ-induced seizures and kindling [33]. In the current work, PTZ kindling increased the level of MDA and decreased the GSH level in the rat aorta and serum. PTZ thus caused an imbalance between antioxidant and oxidant defense system which may be at least partially responsible for seizures and vascular risks. Co-administration of LTG attenuated the rise in serum and tissue MDA levels. The significant decrease in tissue MDA levels with concomitant LTG administration as compared to PTZ alone treated rats indicates an attenuation of lipid peroxidation.
This could be explained by the additive action of LTG on inhibition of glutamate-mediated excitotoxicity, which would lead to less production of free radicals [34]. LTG-PTZ treated group also showed no significant decrease in GSH activity as compared to the PTZ treated group of rats. In assessment of the effect of lamotrigine on cognitive function and oxidative stress during pentylenetetrazole (PTZ)-kindling in mice, Agarwal et al. [6] reported that LTG did not show significant alteration in oxidative stress parameters indicating that this drug does not cause induction of oxidative stress. In addition, Pavone and Cardile [35] reported anti-oxidative potential of LTG in rats.
Current work revealed that aortic rings isolated from epileptic rats showed enhanced contractility toward PE with a significant increase in E-max and decrease in EC50 with impaired relaxation by Ach which denotes endothelial dysfunction. Administration of LTG in epileptic rats showed reduction in the PE-induced contraction with improvements of the endothelium-dependent relaxation. That could be explained by the reducing effects of LTG on MDA levels and aortic GSH, moreover its significant decrease of serum cholesterol, triglyceride levels and LDL-cholesterol levels.
Histopathological studies in thoracic aorta and coronary arteries showed apparently irregular tunica media of endothelium of thoracic aorta with multiple vacuoles in the tunica intima and tunica media of the coronary arteries and adherence of blood elements to the endothelium of coronary artery in PTZ treated rats by H&E when compared to control group. LTG administration to PTZ-LTG treated rats resulted in apparently regular tunica intima of thoracic aorta and few vacuolated cells in tunica media of coronary arteries.
Many studies reported a favorable effect of LTG on vascular dysfunction; Seçkin et al. [36] demonstrated that oral administration of LTG has marked neuro-protective effect and significantly attenuate cerebral vasospasm after subarachnoid hemorrhage. This was explained by the ability of LTG an antiepileptic drug with multi-ion channel inhibition properties to prevent cerebral vasospasm and subsequent neural ischemia in a rabbit model of subarachnoid hemorrhage.
The present study demonstrates that LTG was effective in attenuating PTZ induced kindling seizures. It improved endothelial dysfunction, dyslipidemia and decreased MDA level. Histopathological examination revealed that LTG had a neuro and vascular protective effects as indicated by decreased neurodegeneration and atherosclerosis of aortas and coronaries.
Conclusion
LTG decreased seizures severity, hippocampal damage and improved vascular risk markers in rat model of pentylenetetrazole induced kindling seizure.
Further studies are needed to explain and clarify other mechanisms of the neuroprotective and vasculoprotective effect of LTG.
ABBREVIATIONS
- PTZ
Pentylenetetrazole
- LTG
lamotrigine
- AEDs
antiepileptic drugs
- tHcy
total homocysteine
- MDA
malondialdehyde
- GSH
glutathione
References
- 1.Lopinto-Khoury C, Mintzer S. Antiepileptic drugs and markers of vascular risk. Curr Treat Options Neurol. 2010;12:300–308. doi: 10.1007/s11940-010-0080-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit. 2004;10:MT50–MT52. [PubMed] [Google Scholar]
- 3.Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 2006;71:229–232. doi: 10.1016/j.eplepsyres.2006.06.015. [DOI] [PubMed] [Google Scholar]
- 4.Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta. 2001;303:19–24. doi: 10.1016/s0009-8981(00)00337-5. [DOI] [PubMed] [Google Scholar]
- 5.Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang WN, Chuang YC. Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia. 2009;50:1579–1586. doi: 10.1111/j.1528-1167.2009.02024.x. [DOI] [PubMed] [Google Scholar]
- 6.Agarwal NB, Agarwal NK, Mediratta PK, Sharma KK. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure. 2011;20:257–262. doi: 10.1016/j.seizure.2010.12.006. [DOI] [PubMed] [Google Scholar]
- 7.Martinc B, Grabnar I, Vovk T. The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr Neuropharmacol. 2012;10:328–343. doi: 10.2174/157015912804143504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94:5923–5928. doi: 10.1073/pnas.94.11.5923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Marangos PJ, Loftus T, Wiesner J, Lowe T, Rossi E, Browne CE, Gruber HE. Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia. 1990;31:239–246. doi: 10.1111/j.1528-1157.1990.tb05371.x. [DOI] [PubMed] [Google Scholar]
- 10.Schwarz S, Zhou GZ. N-methyl-D-aspartate receptors and CNS symptoms of homocystinuria. Lancet. 1991;337:1226–1227. doi: 10.1016/0140-6736(91)92900-m. [DOI] [PubMed] [Google Scholar]
- 11.Guilland JC, Favier A, Potier de Courcy G, Galan P, Hercberg S. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease. Basic data. Pathol Biol (Paris) 2003;51:101–110. doi: 10.1016/s0369-8114(03)00104-4. [DOI] [PubMed] [Google Scholar]
- 12.Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 2008;83:1203–1212. doi: 10.4065/83.11.1203. [DOI] [PubMed] [Google Scholar]
- 13.Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53:120–128. doi: 10.1111/j.1528-1167.2011.03316.x. [DOI] [PubMed] [Google Scholar]
- 14.Cunningham MO, Jones RS. The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro. Neuropharmacology. 2000;39:2139–2146. doi: 10.1016/s0028-3908(00)00051-4. [DOI] [PubMed] [Google Scholar]
- 15.Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol. 2004;73:1–60. doi: 10.1016/j.pneurobio.2004.03.009. [DOI] [PubMed] [Google Scholar]
- 16.Mortazavi F, Ericson M, Story D, Hulce VD, Dunbar GL. Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats. Epilepsy Behav. 2005;7:629–638. doi: 10.1016/j.yebeh.2005.08.019. [DOI] [PubMed] [Google Scholar]
- 17.Chen J, Quan QY, Yang F, Wang Y, Wang JC, Zhao G, Jiang W. Effects of lamotrigine and topiramate on hippocampal neurogenesis in experimental temporal-lobe epilepsy. Brain Res. 2010;1313:270–282. doi: 10.1016/j.brainres.2009.12.024. [DOI] [PubMed] [Google Scholar]
- 18.Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281–294. doi: 10.1016/0013-4694(72)90177-0. [DOI] [PubMed] [Google Scholar]
- 19.Malhotra J, Gupta YK. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br J Pharmacol. 1997;120:282–288. doi: 10.1038/sj.bjp.0700869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-aged Greek children. Pediatrics. 1998;101:861–864. doi: 10.1542/peds.101.5.861. [DOI] [PubMed] [Google Scholar]
- 21.Bhattacharya A, Smith GF, Cohen ML. Effect of LY287045, a thrombin/trypsin inhibitor, on thrombin and trypsin-induced aortic contraction and relaxation. J Pharmacol Exp Ther. 2001;297:573–581. [PubMed] [Google Scholar]
- 22.Kiernan JA. Histological and histochemical methods: theory and practice. 3rd ed. Oxford: Linacre House, Jordan Hill; 1999. p. 94. [Google Scholar]
- 23.Bancroft J, Gamble M. Theory and practice of histological techniques. 5th ed. London, Edinburgh, New York, Philadelphia, St. Louis, Sydney, Toronto: Churchill Livingstone; 2002. p. 373. [Google Scholar]
- 24.Jyoti A, Sethi P, Sharma D. Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy Behav. 2009;14:300–308. doi: 10.1016/j.yebeh.2008.11.011. [DOI] [PubMed] [Google Scholar]
- 25.Bharal N, Sahaya K, Jain S, Mediratta PK, Sharma KK. Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice. Phytother Res. 2008;22:1660–1664. doi: 10.1002/ptr.2551. [DOI] [PubMed] [Google Scholar]
- 26.Kumar G, Jones NC, Morris MJ, Rees S, O'Brien TJ, Salzberg MR. Early life stress enhancement of limbic epileptogenesis in adult rats: mechanistic insights. PLoS One. 2011;6:e24033. doi: 10.1371/journal.pone.0024033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kullo IJ, Ballantyne CM. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80:219–230. doi: 10.4065/80.2.219. [DOI] [PubMed] [Google Scholar]
- 28.Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol. 2009;65:448–456. doi: 10.1002/ana.21615. [DOI] [PubMed] [Google Scholar]
- 29.Unlüçerçi Y, Bekpinar S, Gürdöl F, Seferoğlu G. A study on the relationship between homocysteine and diabetic nephropathy in rats. Pharmacol Res. 2002;45:249–252. doi: 10.1006/phrs.2001.0942. [DOI] [PubMed] [Google Scholar]
- 30.Sener U, Zorlu Y, Karaguzel O, Ozdamar O, Coker I, Topbas M. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure. 2006;15:79–85. doi: 10.1016/j.seizure.2005.11.002. [DOI] [PubMed] [Google Scholar]
- 31.Gidal BE, Tamura T, Hammer A, Vuong A. Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Res. 2005;64:161–166. doi: 10.1016/j.eplepsyres.2005.03.005. [DOI] [PubMed] [Google Scholar]
- 32.Mueller SG, Trabesinger AH, Boesiger P, Wieser HG. Brain glutathione levels in patients with epilepsy measured by in vivo (1)H-MRS. Neurology. 2001;57:1422–1427. doi: 10.1212/wnl.57.8.1422. [DOI] [PubMed] [Google Scholar]
- 33.Ono H, Sakamoto A, Sakura N. Plasma total glutathione concentrations in epileptic patients taking anticonvulsants. Clin Chim Acta. 2000;298:135–143. doi: 10.1016/s0009-8981(00)00286-2. [DOI] [PubMed] [Google Scholar]
- 34.Gupta YK, Malhotra J. Antiepileptic drug therapy in the twenty first century. Indian J Physiol Pharmacol. 2000;44:8–23. [PubMed] [Google Scholar]
- 35.Pavone A, Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia. 2003;44(Suppl 10):34–39. doi: 10.1046/j.1528-1157.44.s10.5.x. [DOI] [PubMed] [Google Scholar]
- 36.Seçkin H, Yigitkanli K, Besalti O, Kosemehmetoglu K, Ozturk E, Simsek S, Belen D, Bavbek M. Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol. 2008;70:344–351. doi: 10.1016/j.surneu.2007.07.052. [DOI] [PubMed] [Google Scholar]